Invention Grant
- Patent Title: Anti-RSV immunogens and methods of immunization
- Patent Title (中): 抗RSV免疫原和免疫方法
-
Application No.: US13763822Application Date: 2013-02-11
-
Publication No.: US08771706B2Publication Date: 2014-07-08
- Inventor: Larry J. Anderson , Lia M. Haynes , Ralph A. Tripp
- Applicant: The United States of America being represented by the Secretary of the Department of
- Applicant Address: US DC Washington
- Assignee: The United States of America, as represented by the Secretary of the Department of Health and Human Services
- Current Assignee: The United States of America, as represented by the Secretary of the Department of Health and Human Services
- Current Assignee Address: US DC Washington
- Agency: Gifford, Krass, Sprinkle, Anderson & Citkowski, P.C.
- Main IPC: A61K39/155
- IPC: A61K39/155
Abstract:
Immunogenic polypeptides corresponding to one or more RSV G glycoproteins, or analogs thereof, are provided as components of vaccines. The inventive compositions are useful as both a prophylactic and therapeutic for the prevention and treatment of RSV infections and associated pulmonary or other diseases. The inventive immunogens include regions of the RSV G protein, specifically, amino acid residues 164-176 of RSV G A2 protein or analogs thereof. This inventive immunogen is operable alone or in combination with other polypeptides such as the RSV G protein amino acid residues 155-206, or other vaccines such as live RSV vaccines, or inactivated RSV vaccines or immunogenic analogs thereof.
Public/Granted literature
- US20130136759A1 ANTI-RSV IMMUNOGENS AND METHODS OF IMMUNIZATION Public/Granted day:2013-05-30
Information query
